PRMT3 and non-small cell lung carcinoma: The results showed that the expression of ADM, BIRC5, C1QL1, CCNA2, DKK1, FAM160A1, HMGA2, HNRNPA2B1, HOXCB, NECTIN1, PPIH, PRMT3, STC2, and ZWILCH was significantly increased in NSCLC samples compared to standard samples (Figure 7).